Janwillem Naesens

Directeur/Membre du Conseil chez Frontier Medicines Corp.

Profil

Janwillem Naesens currently works at Cristal Delivery BV, as Director, OCTIMET Oncology NV, as Director, Highlight Therapeutics SL, as Director, Frontier Medicines Corp., as Director, Black Belt Therapeutics Ltd., as Director, DF II LP NV, as Director, and Droia Ventures, as Managing Partner from 2013.
Mr. Naesens also formerly worked at Convert Pharmaceuticals SA, as Chief Executive Officer & Director, NormOxys, Inc., as Director, Cyteir Therapeutics, Inc., as Independent Director from 2019 to 2022, Tusk Therapeutics Ltd., as Director, and Waterland Private Equity NV, as Investment Manager from 2011 to 2013.
Mr. Naesens received his graduate degree in 2005 from Katholieke Universiteit Leuven, undergraduate degree in 2004 from Télécom Paris, and Masters Business Admin degree in 2008 from INSEAD.

Postes actifs de Janwillem Naesens

Sociétés	Poste	Début
DROIA NV	Private Equity Investor	01/09/2013
Frontier Medicines Corp.	Directeur/Membre du Conseil	-
DF II LP NV	Directeur/Membre du Conseil	-
Highlight Therapeutics SL	Directeur/Membre du Conseil	-
OCTIMET Oncology NV	Directeur/Membre du Conseil	-
Cristal Delivery BV	Directeur/Membre du Conseil	-
Black Belt Therapeutics Ltd.	Directeur/Membre du Conseil	-

Anciens postes connus de Janwillem Naesens

Sociétés	Poste	Fin
CYTEIR THERAPEUTICS, INC.	Directeur/Membre du Conseil	15/06/2022
Waterland Private Equity NV	Private Equity Investor	30/09/2013
░░░░ ░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-
░░░░░░░ ░░░░░░░░░░░░░░░ ░░	░░░░░░░░░ ░░░░░░░░░	-
░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	-